03Oct 2023
Malaria vaccine by Oxford & Serum Institute of India gets WHO
recommendation

Malaria vaccine by Oxford & Serum Institute of India gets WHO recommendation

The University of Oxford and Serum Institute of India (SII) have jointly developed a game-changing malaria vaccine, the R21/Matrix-M. This groundbreaking vaccine, endorsed by the WHO, is cost-effective and can be produced on a large scale, offering hope to malaria-endemic countries. Serum Institute of India can have 100 million doses annually, with plans to double that in the next two years. With half a million annual malaria-related deaths worldwide, this vaccine promises a significant impact.

  • #family health

Like

Save

Share